skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
7265152
Issue Dt:
09/04/2007
Application #:
10699336
Filing Dt:
10/31/2003
Publication #:
20040162318
Pub Dt:
08/19/2004
Inventors:
Ashis K. Saha, Christopher J. Burns, Alfred M. Del Vecchio, Thomas R. Bailey et al
Title:
BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES
Assignment: 1
Reel/Frame:
015081/0253Recorded: 08/19/2004Pages: 14
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
SAHA, ASHIS K.
Exec Dt:
12/12/2003
BURNS, CHRISTOPHER J.
Exec Dt:
12/12/2003
DEL VECCHIO, ALFRED M.
Exec Dt:
12/12/2003
BAILEY, THOMAS R.
Exec Dt:
12/11/2003
KULKARNI, BHEEMASHANKAR A.
Exec Dt:
12/12/2003
FAITG, THOMAS H.
Exec Dt:
12/12/2003
RIPPIN, SUSAN R.
Exec Dt:
12/11/2003
BLACKLEDGE, CHARLES W.
Exec Dt:
12/12/2003
RYS, DAVID J.
Exec Dt:
12/17/2003
LESSEN, THOMAS A.
Exec Dt:
12/11/2003
SWESTOCK, JOHN
Exec Dt:
12/12/2003
DENG, YIJUN
Exec Dt:
12/12/2003
NITZ, THEODORE J.
Exec Dt:
12/12/2003
REINHARDT, JASON A.
Exec Dt:
01/19/2004
FENG, HAO
Exec Dt:
01/07/2004
Assignees:
VIROPHARMA INCORPORATED
405 EAGLEVIEW BOULEVARD
EXTON, PENNSYLVANIA 19341
WYETH
FIVE GIRALDA FARMS
MADISON, NEW JERSEY 07940
Correspondent:
DANN DORFMAN HERRELL, ET AL.
PATRICK J. HAGAN, ESQ.
1601 MARKET STREET
SUITE 2400
PHILADELPHIA, PA 19103
Assignment: 2
Reel/Frame:
016039/0827Recorded: 04/08/2005Pages: 14
Conveyance:
SEE RECORDING AT REEL 016082 FRAME 0475 (DOCUMENT RECORDED OVER TO ADD AN OMITTED PAGE TO A CORRECTIVE DOCUMENT; THEREFORE, CHANGING THE NUMBER OF MICROFILMED PAGES FROM 14 TO 15)
Assignors:
SAHA, ASHIS K.
Exec Dt:
12/12/2003
BURNS, CHRISTOPHER J.
Exec Dt:
12/12/2003
DEL VECCHIO, ALFRED M.
Exec Dt:
12/12/2003
BAILEY, THOMAS R.
Exec Dt:
12/11/2003
KULKARNI, BHEEMASHANKAR A.
Exec Dt:
12/12/2003
FAITG, THOMAS H.
Exec Dt:
12/12/2003
RIPPIN, SUSAN R.
Exec Dt:
12/11/2003
BLACKLEDGE, CHARLES W.
Exec Dt:
12/12/2003
RYS, DAVID J.
Exec Dt:
12/17/2003
LESSEN, THOMAS A.
Exec Dt:
12/11/2003
SWESTOCK, JOHN
Exec Dt:
12/12/2003
DENG, YIJUN
Exec Dt:
12/12/2003
NITZ, THEODORE J.
Exec Dt:
12/12/2003
REINHARDT, JASON A.
Exec Dt:
01/19/2004
FENG, HAO
Exec Dt:
01/07/2004
Assignees:
VIROPHARMA INCORPORATED
405 EAGLEVIEW BOULEVARD
EXTON, PENNSYLVANIA 19341
WYETH
FIVE GIRALDA FARMS
MADISON, NEW JERSEY 07940
Correspondent:
DANN DORFMAN HERRELL ET AL
PATRICK J. HAGAN, ESQ.
1601 MARKET STREET, SUITE 2400
PHILADELPHIA, PA 19103
Assignment: 3
Reel/Frame:
016082/0475Recorded: 05/26/2005Pages: 15
Conveyance:
CORRECTION - TO REMOVE INCORRECT SERIAL NO. 10/669,335 AT REEL 015081 FRAME 0253
Assignors:
SAHA, ASHIS K.
Exec Dt:
12/12/2003
BURNS, CHRISTOPHER J.
Exec Dt:
12/12/2003
DEL VECCHIO, ALFRED M.
Exec Dt:
12/12/2003
BAILEY, THOMAS R.
Exec Dt:
12/11/2003
KULKAML, BHEEMASHANKAR A.
Exec Dt:
12/12/2003
FAITG, THOMAS H.
Exec Dt:
12/12/2003
RIPPIN, SUSAN R.
Exec Dt:
12/11/2003
BLACKLEDGE, CHARLES W.
Exec Dt:
12/12/2003
FLYS, DAVID J.
Exec Dt:
12/17/2003
LESSEN, THOMAS A.
Exec Dt:
12/11/2003
SWESTOCK, JOHN
Exec Dt:
12/12/2003
DENG, YIJUN
Exec Dt:
12/12/2003
NITZ, THEODORE J.
Exec Dt:
12/12/2003
REINHARDT, JASON A.
Exec Dt:
01/19/2004
FENG, HAO
Exec Dt:
01/07/2004
Assignees:
VIROPHARMA INCORPORATED
405 EAGLEVIEW BOULEVARD
EXTON, PENNSYLVANIA 19341
WYETH
FIVE GIRALDA FARMS
MADISON, NEW JERSEY 07940
Correspondent:
PATRICK J. HAGAN, ESQ.
DANN DORFMAN, HERRELL & SKILLMAN, P.C.
1601 MARKET STREET, SUITE 2400
PHILADELPHIA, PA 19103

Search Results as of: 05/22/2024 12:12 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT